Constructing endophenotypes of complex diseases using non-negative matrix factorization and adjusted rand index

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Wang, Hui Min ^a   Hsiao, Ching Lin ^b   Hsieh, Ai Ru ^b   Lin, Ying Chao ^b   Fann, Cathy S J ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUSTED RAND INDEX; ALZHEIMER DISEASE; ANALYTICAL PARAMETERS; ARTICLE; CLUSTER ANALYSIS; DATA PROCESSING; ENDOPHENOTYPE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC PARAMETERS; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT; METAGENE; NON NEGATIVE MATRIX FACTORIZATION; PRINCIPAL COMPONENT ANALYSIS; SIMULATION;

ALGORITHMS; ALZHEIMER DISEASE; CLUSTER ANALYSIS; COMPUTER SIMULATION; ENDOPHENOTYPES; GENE EXPRESSION PROFILING; GENETIC DISEASES, INBORN; GENOTYPE; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84864000753     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040996     Document Type: Article

References (76)

1. Gottesman II, Gould TD, (2003) The endophenotype concept in psychiatry: Etymology and strategic intentions. American Journal of Psychiatry 160: 636-645.
2. Hoshida Y, Brunet JP, Tamayo P, Golub TR, Mesirov JP, (2007) Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets. Plos One 2.
3. Zhang WS, Rekaya R, Bertrand K, (2006) A method for predicting disease subtypes in presence of misclassification among training samples using gene expression: application to human breast cancer. Bioinformatics 22: 317-325.
4. Mosca L, Fabris S, Lionetti M, Todoerti K, Agnelli L, et al. (2010) Integrative Genomics Analyses Reveal Molecularly Distinct Subgroups of B-Cell Chronic Lymphocytic Leukemia Patients with 13q14 Deletion. Clinical Cancer Research 16: 5641-5653.
5. Smesny S, Klemm S, Stockebrand M, Grunwald S, Gerhard UJ, et al. (2007) Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in Schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids 77: 79-85.
6. Boon K, Bailey NW, Yang J, Steel MP, Groshong S, et al. (2009) Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF). Plos One 4.
7. Huber KE, Carey LA, Wazer DE, (2009) Breast Cancer Molecular Subtypes in Patients With Locally Advanced Disease: Impact on Prognosis, Patterns of Recurrence, and Response to Therapy. Seminars in Radiation Oncology 19: 204-210.
8. Sorlie T, Wang YL, Xiao CL, Johnsen H, Naume B, et al. (2006) Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. Bmc Genomics 7.
9. Kaminsky Z, Wang SC, Petronis A, (2006) Complex disease, gender and epigenetics. Annals of Medicine 38: 530-544.
10. Anguiano A, Tuchman SA, Acharya C, Salter K, Gasparetto C, et al. (2009) Gene Expression Profiles of Tumor Biology Provide a Novel Approach to Prognosis and May Guide the Selection of Therapeutic Targets in Multiple Myeloma. Journal of Clinical Oncology 27: 4197-4203.
11. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, et al. (2004) Genetic analysis of genome-wide variation in human gene expression. Nature 430: 743-747.
12. Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, et al. (2005) Mapping determinants of human gene expression by regional and genome-wide association. Nature 437: 1365-1369.
13. Zou F, Carrasquillo MM, Pankratz VS, Belbin O, Morgan K, et al. (2010) Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease. Neurology 74: 480-486.
14. Lynn KS, Li LL, Lin YJ, Wang CH, Sheng SH, et al. (2009) A neural network model for constructing endophenotypes of common complex diseases: an application to male young-onset hypertension microarray data. Bioinformatics 25: 981-988.
15. Pan WH, Lynn KS, Chen CH, Wu YL, Lin CY, et al. (2006) Using endophenotypes for pathway clusters to map complex disease genes. Genetic Epidemiology 30: 143-154.
16. Yeung KY, Ruzzo WL, (2001) Principal component analysis for clustering gene expression data. Bioinformatics 17: 763-774.
17. Alter O, Brown PO, Botstein D, (2000) Singular value decomposition for genome-wide expression data processing and modeling. Proceedings of the National Academy of Sciences of the United States of America 97: 10101-10106.
18. Kong W, Vanderburg CR, Gunshin H, Rogers JT, Huang XD, (2008) A review of independent component analysis application to microarray gene expression data. Biotechniques 45: 501-+.
19. Carmona-Saez P, Pascual-Marqui RD, Tirado F, Carazo JM, Pascual-Montano A, (2006) Biclustering of gene expression data by non-smooth non-negative matrix factorization. Bmc Bioinformatics 7.
20. Lee DD, Seung HS, (1999) Learning the parts of objects by non-negative matrix factorization. Nature 401: 788-791.
21. Andre F, Job B, Dessen P, Tordai A, Michiels S, et al. (2009) Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array. Clinical Cancer Research 15: 441-451.
22. Lohmann G, Volz KG, Ullsperger M, (2007) Using non-negative matrix factorization for single-trial analysis of fMRI data. Neuroimage 37: 1148-1160.
23. Yoshihara K, Tajima A, Komata D, Yamamoto T, Kodama S, et al. (2009) Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis. Cancer Science 100: 1421-1428.
24. Brunet JP, Tamayo P, Golub TR, Mesirov JP, (2004) Metagenes and molecular pattern discovery using matrix factorization. Proceedings of the National Academy of Sciences of the United States of America 101: 4164-4169.
25. Liu WX, Yuan KH, Ye DT, (2008) Reducing microarray data via nonnegative matrix factorization for visualization and clustering analysis. Journal of Biomedical Informatics 41: 602-606.
26. Ross DA, Zemel RS, (2006) Learning parts-based representations of data. Journal of Machine Learning Research 7: 2369-2397.
27. Webster JA, Gibbs JR, Clarke J, Ray M, Zhang WX, et al. (2009) Genetic Control of Human Brain Transcript Expression in Alzheimer Disease. American Journal of Human Genetics 84: 445-458.
28. Monti S, Tamayo P, Mesirov J, Golub T, (2003) Consensus clustering: A resampling-based method for class discovery and visualization of gene expression microarray data. Machine Learning 52: 91-118.
29. Gaujoux R, Seoighe C, (2010) A flexible R package for nonnegative matrix factorization. Bmc Bioinformatics 11.
30. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T, (2007) Pathway mapping tools for analysis of high content data. Methods Mol Biol 356: 319-350.
31. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A, (2005) A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicology Letters 158: 20-29.
32. Ma SG, Dai Y, (2011) Principal component analysis based methods in bioinformatics studies. Briefings in Bioinformatics 12: 714-722.
33. Fogel P, Young SS, Hawkins DM, Ledirac N, (2007) Inferential, robust non-negative matrix factorization analysis of microarray data. Bioinformatics 23: 44-49.
34. Allison DB, Gadbury GL, Heo MS, Fernandez JR, Lee CK, et al. (2002) A mixture model approach for the analysis of microarray gene expression data. Computational Statistics & Data Analysis 39: 1-20.
35. Li H, Deng HW, (2010) Systems genetics, bioinformatics and eQTL mapping. Genetica 138: 915-924.
36. Michaelson JJ, Loguercio S, Beyer A, (2009) Detection and interpretation of expression quantitative trait loci (eQTL). Methods 48: 265-276.
37. Michaelson JJ, Alberts R, Schughart K, Beyer A, (2010) Data-driven assessment of eQTL mapping methods. Bmc Genomics 11.
38. Williams RBH, Chan EKF, Cowley MJ, Little PFR, (2007) The influence of genetic variation on gene expression. Genome Research 17: 1707-1716.
39. Wang DX, Sadee W, (2006) Searching for polymorphisms that affect gene expression and mRNA processing: Example ABCB1 (MDR1). Aaps Journal 8: E515-E520.
40. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, et al. (2007) Population genomics of human gene expression. Nature Genetics 39: 1217-1224.
41. Chen YQ, Zhu J, Lum PY, Yang X, Pinto S, et al. (2008) Variations in DNA elucidate molecular networks that cause disease. Nature 452: 429-435.
42. Kim H, Park H, (2007) Sparse non-negative matrix factorizations via alternating non-negativity-constrained least squares for microarray data analysis. Bioinformatics 23: 1495-1502.
43. Langfelder P, Horvath S, (2008) WGCNA: an R package for weighted correlation network analysis. Bmc Bioinformatics 9.
44. McCarthy MI, Hirschhorn JN, (2008) Genome-wide association studies: past, present and future. Hum Mol Genet 17: R100-101.
45. Cupples LA, Arruda HT, Benjamin EJ, D'Agostino Sr RB, Demissie S, et al. (2007) The Framingham Heart Study 100 K SNP genome-wide association study resource: overview of 17 phenotype working group reports. Bmc Medical Genetics 8.
46. Florez JC, Manning AK, Dupuis J, Gianniny L, Irenze K, et al. (2007) Genome-wide association with diabetes-related traits in the Framingham heart study. Diabetes 56: A94-A94.
47. Tabangin ME, Woo JG, Martin LJ, (2009) The effect of minor allele frequency on the likelihood of obtaining false positives. BMC Proc 3: S41.
48. Browning BL, Browning SR, (2009) A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. American Journal of Human Genetics 84: 210-223.
49. Devarajan K, (2008) Nonnegative Matrix Factorization: An Analytical and Interpretive Tool in Computational Biology. Plos Computational Biology 4.
50. Ferrand A, Wang TC, (2006) Gastrin and cancer: a review. Cancer Lett 238: 15-29.
51. Dufresne M, Seva C, Fourmy D, (2006) Cholecystokinin and gastrin receptors. Physiol Rev 86: 805-847.
52. Grabowska AM, Watson SA, (2007) Role of gastrin peptides in carcinogenesis. Cancer Lett 257: 1-15.
53. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG, (1998) Dopamine receptors: from structure to function. Physiol Rev 78: 189-225.
54. Salma J, McDermott JC, (2012) Suppression of a MEF2-KLF6 Survival Pathway by PKA Signaling Promotes Apoptosis in Embryonic Hippocampal Neurons. Journal of Neuroscience 32: 2790-2803.
55. Heidenreich KA, Linseman DA, (2004) Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival. Molecular Neurobiology 29: 155-165.
56. Cruz JC, Tsai LH, (2004) Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends in Molecular Medicine 10: 452-458.
57. Goodnough LT, Skikne B, Brugnara C, (2000) Erythropoietin, iron, and erythropoiesis. Blood 96: 823-833.
58. Bieber E, (2001) Erythropoietin, the biology of erythropoiesis and epoetin alfa- An overview. Journal of Reproductive Medicine 46: 521-530.
59. Ghezzi P, Brines M, (2004) Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death and Differentiation 11: S37-S44.
60. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE, (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genetics 39: 17-23.
61. Kamboh MI, (2004) Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet 68: 381-404.
62. Hollingworth P, Sweet R, Sims R, Harold D, Russo G, et al. (2011) Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry.
63. Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, et al. (2007) A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 68: 613-618.
64. Cohen J, (1992) A power primer. Psychol Bull 112: 155-159.
65. Allison DB, Cui X, Page GP, Sabripour M, (2006) Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 7: 55-65.
66. Boone PM, Wiszniewski W, Lupski JR, (2011) Genomic medicine and neurological disease. Hum Genet 130: 103-121.
67. Jonsson G, Staaf J, Vallon-Christersson J, Ringner M, Holm K, et al. (2010) Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Research 12.
68. Gao Y, Church G, (2005) Improving molecular cancer class discovery through sparse non-negative matrix factorization. Bioinformatics 21: 3970-3975.
69. Carrasco DR, Tonon G, Huang YS, Zhang YY, Sinha R, et al. (2006) High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 9: 313-325.
70. Fan HT, Hegde PS, (2005) The transcriptome in blood: Challenges and solutions for robust expression profiling. Current Molecular Medicine 5: 3-10.
71. Nica AC, Dermitzakis ET, (2008) Using gene expression to investigate the genetic basis of complex disorders. Hum Mol Genet 17: R129-R134.
72. Beazely MA, Tong A, Wei WL, Van Tol H, Sidhu B, et al. (2006) D2-class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet-derived growth factor receptor-dependent. J Neurochem 98: 1657-1663.
73. Roesler R, Kapczinski F, Quevedo J, Dal Pizzol F, Schwartsmann G, (2007) The gastrin-releasing peptide receptor as a therapeutic target in central nervous system disorders. Recent Pat CNS Drug Discov 2: 125-129.
74. Linseman DA, McClure ML, Bouchard RJ, Laessig TA, Ahmadi FA, et al. (2002) Suppression of death receptor signaling in cerebellar Purkinje neurons protects neighboring granule neurons from apoptosis via an insulin-like growth factor I-dependent mechanism. Journal of Biological Chemistry 277: 24546-24553.
75. Kawakami M, Iwasaki S, Sato K, Takahashi M, (2000) Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells. Biochem Biophys Res Commun 279: 293-297.
76. R Development Core Team, R (2011) a language and environment for statistical computing, R Foundation for Statistical Computing, Vienna, Austria. http://www.r-project.org.